SCHEMBL28529491

SCHEMBL28529491

[CH2]CCOc1ncc([N+](=O)[O-])cc1-c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 1/20 0.45
ALDH1A1 P00352 2/20 0.44
CYP19A1 P11511 7/20 0.43
CYP11B1 P15538 7/20 0.43
CYP11B2 P19099 7/20 0.43
MAPT P10636 3/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
LMNA P02545 1/20 0.41
XBP1 P17861 1/20 0.41
MAPK1 P28482 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
PTGS2 P35354 2/20 0.39
RAB9A P51151 2/20 0.38
NPC1 O15118 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2404313 0.83 CYP19A1 (0.57) PTGDR2ALDH1A1CYP19A1CYP11B1CYP11B2
SCHEMBL21513332 0.83 HRH3 (0.44) PTGDR2ALDH1A1CYP19A1CYP11B1CYP11B2
SCHEMBL2404284 0.81 ALDH1A1 (0.49) PTGDR2ALDH1A1CYP19A1CYP11B1CYP11B2
SCHEMBL2404650 0.74 ALDH1A1 (0.50) PTGDR2ALDH1A1MAPTMEN1KMT2A
SCHEMBL2406691 0.73 ALDH1A1 (0.49) PTGDR2ALDH1A1MAPTMEN1KMT2A
SCHEMBL2403049 0.73 PTGDR2 (0.49) PTGDR2ALDH1A1MAPTMEN1KMT2A
SCHEMBL2404392 0.73 ALDH1A1 (0.49) PTGDR2ALDH1A1MAPTMEN1KMT2A
SCHEMBL14908747 0.73 ALDH1A1 (0.49) PTGDR2ALDH1A1MAPTMEN1KMT2A
SCHEMBL9176504 0.69 TDP1 (0.45) ALDH1A1MAPTMEN1KMT2ALMNA
SCHEMBL2405525 0.69 DHODH (0.47) PTGDR2ALDH1A1CYP19A1CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112469720-B Dual ATM and DNA-PK inhibitors for use in anti-tumor therapy 艾科思莱德制药公司 2024-03-29 CN disclosed
CN-112469720-A Dual ATM and DNA-PK inhibitors for use in antitumor therapy 艾科思莱德制药公司 2021-03-09 CN disclosed